Work

Supplementary Figure 2 from Rapamycin Rescues ABT-737 Efficacy in Small Cell Lung Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 527KB, Supplemental Figure 2. Rapamycin responses in a panel of SCLC cell lines and synergy matrix plots of ABT-737 plus inhibitors of PI3K and mTOR in SCLC cell lines.

DOI: 10.1158/0008-5472.22403949.v1

Authors: Eric E. Gardner, Nick Connis, John T. Poirier, Leslie Cope, Irina Dobromilskaya, Gary L. Gallia, Charles M. Rudin, Christine L. Hann

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361848749

Cites:

Cited by:

Related to: 10